Last Updated On 4/4/2023 4:53:28 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Novartis |
Recipient: You |
Company: Kite/Gilead |
Recipient: You |
Company: Janssen Scientific Affairs |
Recipient: You |
Company: ADC Therapeutics |
Recipient: You |
Company: Iksuda Therapeutics |
Recipient: You |
Company: Bristol-Myers Squibb/Celgene/Juno |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: Genentech/Roche |
Recipient: You |
Company: Abbvie |
Recipient: You |
Company: Merck |
Recipient: You |
Company: Monte Rosa Therapeutics |
Recipient: You |
Company: MorphoSys/Incyte |
Recipient: You |
Company: Seattle Genetics |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Janssen |
Recipient: You |
Company: Genentech |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Kite/Gilead |
Recipient: You |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: MorphoSys/Incyte |
Recipient: You |
Company: ADC Therapeutics |
Recipient: You |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|